The research topics are therefore defined in such a way as to establish Anteis’s coherent innovation policy, which is primarily focused on three specific fields:
- Ophthalmology
- Orthopaedics
- Aesthetic Dermatology.
Urology, surgery and pharmacology are also important research fields for the group. For each of them, depending on the patents filed, Anteis has defined priority speciality tracks. These are:
| In ophthalmology | Viscoelastic gels (OVDs – ophthalmic viscosurgical devices) Injectable devices for glaucoma surgery |
| In orthopaedics | Gels to treat articular degeneration |
| In aesthetic dermatology | Wrinkle-filling gels Resorbable implants Cutaneous rehydration gels |
| In general dermatology | Devices that favour healing |
| In surgery | Gels favouring bone reconstruction |
| In urology | Gels for the treatment of incontinence |
| In pharmacology | Gels with controlled release (ADDS*) of active ingredients. (*) Advanced Drug Delivery System |
To successfully carry out its various missions, the R&D department calls on solid know-how in chemistry, biochemistry, physics and biophysics.
The teams who work on different projects have specific know-how in the following
disciplines:
- Chemical transformation of biopolymers (cross-linking, grafting)
- Purification of biopolymer-based gels
- Formulation of biopolymer-based gels
- Analysis of the rheological behaviour of biopolymer-based gels
- Physical-chemical and microbiological analysis of biopolymer-based gels
- Biochemistry and biophysics of injectable biopolymer-based gels
- Clinical study of injectable biopolymer-based gels.
recommendprint this page top
